MaxCyte, Inc Company Profile

22:25 EDT 22nd June 2018 | BioPortfolio

MaxCyte is a clinical-stage cell therapeutics company with a growing pipeline of proprietary and partnered drug candidates. Programs in development are based on MaxCyte's platform technology which breaks down the barriers to ex vivo cell loading and the manufacture of viral vectors. MaxCyte's pipeline includes one product in Phase I/II clinical trials for the treatment of Chronic Lymphocytic Leukemia (CLL) and several preclinical candidates to treat a variety of diseases with unmet needs. The company also offers its unparalleled, customizable technology to collaborators who take advantage of its advanced capabilities for cell-based therapeutic development and biotherapeutic manufacturing. Partners are currently working to develop therapeutics for pulmonary disease, congenital heart disease and cancer


22 Firstfield Road, Suite 250
United States of America


Phone: 301-944-1700
Fax: (301) 944-1703

News Articles [14 Associated News Articles listed on BioPortfolio]

MaxCyte prepares for phase I study of potential cancer breakthrough; says trading in line with market expectations

MaxCyte said it is in active discussions with the US Food & Drug Administration to begin the study of MCY-M11

NIH and MaxCyte to develop new sickle cell disease therapies

The US National Institutes of Health (NIH) has signed a cooperative research and development agreement (CRADA) with life sciences company...Read More... The post NIH and MaxCyte to develop new sickle ...

MaxCyte Inc gearing up for phase I study of potential cancer breakthrough

Doug Doerfler, chief executive of MaxCyte Inc (LON:MXCT), tells Proactive they're in a strong financial position as they prepare for the launch of a phase I clinical trial of a cancer treatment whic...

MaxCyte defying the odds as it gears up for pivotal year

£1,000 invested at float two years ago would now be worth just north of £3,500

MaxCyte hails US National Institutes of Health tie-up to find treatment for sickle cell disease

The collaboration will be with National Heart, Lung and Blood Institute, which is part of the NIH

MaxCyte Inc MXCT Financial and Strategic SWOT Analysis Review [Report Updated: 09032018] Prices from USD $300

SummaryMaxCyte Inc MaxCyte is a biotherapeutic company that conducts research and develops cell transfection technologies. The company utilizes flow electroporation technology for discovery, developme...

MaxCyte appoints biotech pioneer as independent director

Richard Douglas was senior vice president of corporate development and corporate officer at Genzyme Corporation from 1989 until the business’ sale to Sanofi in 2011

You’re Invited: BIO Board Member to Discuss Challenges Facing Emerging Biotechs – and How to Fix Them

Next week, MaxCyte CEO and Biotechnology Innovation Organization (BIO) Board Member Doug Doerfler will speak ...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [3 Associated Companies listed on BioPortfolio]

MaxCyte, Inc.

MaxCyte specializes in cell modification technologies to enable the discovery, development, manufacturing, and delivery of innovative therapeutic products. Drawing on its cell the...

MaxCyte, Inc

MaxCyte is a clinical-stage cell therapeutics company with a growing pipeline of proprietary and partnered drug candidates. Programs in development are based on MaxCyte's platform technology which bre...

MEDINET Co., Ltd. and MaxCyte, Inc.

MEDINET is a world leading company in cell therapy, supporting medical service providers in Japan. Through its service, MEDINET provides medical institutions with advanced technol...

More Information about "MaxCyte, Inc" on BioPortfolio

We have published hundreds of MaxCyte, Inc news stories on BioPortfolio along with dozens of MaxCyte, Inc Clinical Trials and PubMed Articles about MaxCyte, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of MaxCyte, Inc Companies in our database. You can also find out about relevant MaxCyte, Inc Drugs and Medications on this site too.

Quick Search


Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Corporate Database Quicklinks

Searches Linking to this Company Record